Bojana Jovanovic

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 3

Top Topics

Major Depressive Disorder

Cell Cycle Arrest

Binding Protein

Top Venues

Science advances

Cancer research

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Bojana Jovanovic, Sarah E Church, Kara M Gorman, Khrystyna North, Edward T Richardson, Molly DiLullo, Victoria Attaya, Julie Kasparian, Ayesha Mohammed-Abreu, Gregory Kirkner, Melissa E Hughes, Nancy U Lin, Elizabeth A Mittendorf, Stuart J Schnitt, Sara M Tolaney, Shom Goel
Integrative multi-omic profiling of triple-negative breast cancer for identifying suitable therapies. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Laura E Stevens, Guillermo Peluffo, Xintao Qiu, Daniel Temko, Anne Fassl, Zheqi Li, Anne Trinh, Marco Seehawer, Bojana Jovanovic, Maša Alečković, Callahan M Wilde, Renee C Geck, Shaokun Shu, Natalie L Kingston, Nicholas W Harper, Vanessa Almendro, Alanna L Pyke, Shawn B Egri, Malvina Papanastasiou, M Kendell Clement, Ningxuan Zhou, Sarah R Walker, Jacqueline Salas, So Yeon Park, David A Frank, Alexander Meissner, Jacob D Jaffe, Piotr Sicinski, Alex Toker, Franziska Michor, Henry W Long, Beth A Overmoyer, Kornelia Polyak
JAK-STAT signaling in inflammatory breast cancer enables chemotherapy-resistant cell states. Cancer research (2022)
Anne Fassl, Christopher Brain, Monther Abu-Remaileh, Iga Stukan, Deborah Butter, Piotr Stepien, Avery S Feit, Johann Bergholz, Wojciech Michowski, Tobias Otto, Qing Sheng, Alice Loo, Walter Michael, Ralph Tiedt, Carmine DeAngelis, Rachel Schiff, Baishan Jiang, Bojana Jovanovic, Karolina Nowak, Maria Ericsson, Michael D Cameron, Nathanael S Gray, Deborah Dillon, Jean J Zhao, David M Sabatini, Rinath M Jeselsohn, Myles Brown, Kornelia Polyak, Piotr Sicinski
Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibition. Science advances 6 (25) (2020)